Clinical predictors of androgen-independent prostate cancer and survival in the prostate-specific antigen era

Author： Oefelein M.G.   Ricchiuti V.S.   Conrad P.W.   Goldman H.   Bodner D.   Resnick M.I.   Seftel A.  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.60, Iss.1, 2002-07, pp. : 120-124

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nadir prostate-specific antigen as a predictor of progression to androgen-independent prostate cancer

By Benaim E.A.   Pace C.M.   Lam P.M.   Roehrborn C.G.  

Urology, Vol. 59, Iss. 1, 2002-01 ,pp. : 73-78

Elsevier

Access to resources Recommend Favorite

Improving survival for patients with prostate cancer diagnosed in the prostate-specific antigen era

By Gilliland F.D.   Hunt W.C.   Key C.R.  

Urology, Vol. 48, Iss. 1, 1996-07 ,pp. : 67-71

Elsevier

Access to resources Recommend Favorite

Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma

By Ghossein R.A.   Rosai J.   Scher H.I.   Seiden M.   Zhang Z.-F.   Sun M.   Chang G.   Berlane K.   Krithivas K.   Kantoff P.W.  

Urology, Vol. 50, Iss. 1, 1997-07 ,pp. : 100-105

Elsevier

Access to resources Recommend Favorite

Methodological and clinical comparison of the ACS prostate-specific antigen assay and the tandem-E prostate-specific antigen assay in prostate cancer

By Schambeck C.M.   Schmeller N.   Stieber P.   Jansen H.-M.   Pahl H.   Schneider W.   Fateh-Moghadam A.  

Urology, Vol. 46, Iss. 2, 1995-08 ,pp. : 195-199

Elsevier

Access to resources Recommend Favorite

Impact of prostate-specific antigen screening on prostate cancer

By Zincke H.  

Urology, Vol. 47, Iss. 5, 1996-05 ,pp. : 783-783

Elsevier

Access to resources Recommend Favorite